Abstract
The prevalence of obstructive sleep apnea (OSA) is estimated to be 1–5% of the adult population world-wide, and in Korea, it is reported at 4.5% of men and 3.2% of women (Age 40 to 69 years old). Active treatment of OSA is associated with decrease in insulin resistance, cardiovascular disease, psychosocial problems, and mortality. Surgical treatment of OSA has evolved in the era of neuromodulation with the advent of hypoglossal nerve stimulation (HGNS). We share this review of HGNS with our maxillofacial surgical colleagues to expand the scope of surgical care for OSA.
| Original language | English |
|---|---|
| Article number | 27 |
| Journal | Maxillofacial Plastic and Reconstructive Surgery |
| Volume | 39 |
| Issue number | 1 |
| DOIs | |
| State | Published - Dec 2017 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2017, The Author(s).
ASJC Scopus Subject Areas
- Surgery
Keywords
- Hypoglossal nerve
- Obstructive sleep apnea
- Oral and maxillofacial surgeon
- OSA surgical treatment
- Sleep endoscopy
- Snoring
- Upper airway stimulation
Fingerprint
Dive into the research topics of 'Hypoglossal nerve stimulation for treatment of obstructive sleep apnea (OSA): a primer for oral and maxillofacial surgeons'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS